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Introduction
Soluble or transmembrane proteins in the ER possessing un-
folded or misfolded parts in their luminal regions are retrotrans-
located back to the cytoplasm and degraded by the proteasome, 
a series of events termed ER-associated degradation (ERAD)-L 
(Xie and Ng, 2010; Smith et al., 2011; Brodsky, 2012).
ERAD-L deals with both glycoproteins (gpERAD) and 
non-glycoproteins (non-gpERAD). Misfolded parts of non-gly-
coproteins are most likely recognized by molecular chaperones 
represented by BiP. In contrast, glycoprotein degradation relies 
on the structure of N-glycans present on the surface of ERAD-L 
substrates. Glc3Man9GlcNAc2 attached to the asparagine resi-
due is trimmed by glucosidase I and II to Man9GlcNAc2, which 
is in turn trimmed to Man8GlcNAc2 and then to Man7GlcNAc2. 
Man7GlcNAc2 exposing α1,6-linked mannose is recognized by 
the lectin molecule for the delivery of ERAD-L substrates to 
the HRD1 E3 complex present in the ER membrane (Molinari, 
2007; Hosokawa et al., 2010; Kamiya et al., 2012).
We have recently conducted comprehensive gene knock-
out (KO) analyses to precisely identify the roles of the four 
α1,2-mannosidase candidates for the mannose trimming that 
occurs during ERAD-L, namely ER mannosidase I (ERmanI), 
EDEM1, EDEM2, and EDEM3. These experiments were per-
formed in chicken DT40 cells using conventional homologous 
recombination and in human HCT116 cells using the tran-
scription activator-like effector nuclease method. Our results 
were surprising (Ninagawa et al., 2014). Initial trimming from 
Man9GlcNAc2 to Man8GlcNAc2 was conducted by EDEM2, 
which had been thought to have no mannosidase activity (Mast 
et al., 2005), whereas subsequent trimming from Man8Glc-
NAc2 to Man7GlcNAc2 was performed mostly by EDEM3 and 
to a slight extent by EDEM1. ERmanI appeared to play only 
a minor role in gpERAD.
Here, by constructing and analyzing DT40 and HCT116 
cells simultaneously deficient in EDEM1/2/3, we show that dif-
ferent ERAD pathways are used depending on the severity of 
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misfolding in the ERAD-L substrates and that non-gpERAD has 
a much more positive role in protein quality control in the ER 
than its previously proposed role as a backup for gpERAD under 
ER stress (Ushioda et al., 2013), as indicated by the finding that 
non-gpERAD is able to clear severely misfolded glycoproteins 
from the ER even in the absence of pharmacological ER stress.
Results and discussion
We constructed EDEM1/2/3 triple KO (TKO) in both DT40 
(gEDEM-TKO; Fig. S1) and HCT116 (hEDEM-TKO; Fig. S2 
A) cells, in which functional EDEM1, EDEM2, or EDEM3 
mRNA was not expressed (Fig. 1, A and C). gEDEM-TKO and 
hEDEM-TKO cells grew slightly more slowly than respective 
wild-type (WT) cells (Fig. 1, A and C). However, ER stress was 
not elicited in these cells because the levels of three ER stress 
marker proteins, BiP, ATF4, and XBP1(S), were not elevated 
(Fig. S2 B). The N-glycan profiles of total cellular glycoproteins 
revealed that M9 level was markedly elevated in gEDEM-TKO 
and hEDEM-TKO cells, similarly to WT DT40 and HCT116 
cells treated with kifunensine, an inhibitor of α1,2-mannosi-
dases in the ER (Fig. 1, B and D), as expected from our previ-
ous results (Ninagawa et al., 2014). Accordingly, degradation 
of endogenous ATF6α, an ERAD-Lm (m for membrane pro-
tein) substrate containing three potential N-glycosylation sites 
(Fig. 3 A) was blocked almost completely in gEDEM-TKO and 
hEDEM-TKO cells (Fig. 1, E and F). The extent of this block-
ade was comparable with that observed in WT cells treated with 
MG132, a proteasome inhibitor, or kifunensine (Ninagawa et 
al., 2014). We also found that hATF6α(C)-TAP, an artificial 
ERAD-Ls (s for soluble protein) substrate containing the lu-
minal region of human ATF6α flanked by the N-terminal sig-
nal sequence and C-terminal tandem affinity purification tag 
(Fig.  3  A), was stabilized in gEDEM-TKO cells (Fig.  1  G). 
During SDS-PAGE, hATF6α(C)-TAP in gEDEM-TKO cells 
migrated slightly more slowly than in WT cells because of the 
defect in mannose trimming, and this difference in migration 
was lost after endoglycosidase H (EndoH) treatment (Fig. 1 H). 
Instability of the native protein ATF6α in WT cells may result 
from intrinsically disordered parts found in its luminal region 
(Rosenbaum et al., 2011).
We next examined the effect of EDEM-TKO on degra-
dation of the null Hong Kong (NHK) variant of α1-proteinase 
inhibitor (α1PI), the most frequently used ERAD-Ls substrate 
(Sifers et al., 1988). Similarly to the case of hATF6α(C)-TAP, 
NHK in gEDEM-TKO cells migrated slightly more slowly than 
in WT cells during SDS-PAGE, and this difference in migration 
was lost after EndoH treatment (Fig. 2 A). In the case of NHK-
QQQ, the nonglycosylated version of NHK and its migration 
positions during SDS-PAGE (Fig. 2 A), as well as its degrada-
tion rate (Fig. 2 B), did not differ between WT and gEDEM-
TKO cells, as expected. However, in marked contrast to the case 
of ATF6α (Ninagawa et al., 2014), we were surprised to find 
that NHK was degraded similarly in WT and gEDEM1/2/3 sin-
gle KO (Fig. 2 C) and in WT and hEDEM1/2/3 single KO cells 
(Fig. 2 F). Furthermore, degradation of NHK was delayed only 
at early chase periods in gEDEM-TKO (Fig. 2 D) and hEDEM-
TKO (Fig.  2  G) cells, and NHK was eventually degraded in 
gEDEM-TKO and hEDEM-TKO cells similarly to the case in 
WT cells. This delay in early chase period was also observed 
in WT DT40 (Fig. 2 E) and HCT116 (Fig. 2, G and H) cells 
treated with kifunensine, whereas NHK degradation was sig-
nificantly delayed at all chase periods in WT DT40 (Fig. 2 E) 
and HCT116 (Fig. 2 H) cells treated with MG132. Kifunensine 
treatment of hEDEM-TKO cells did not affect the degradation 
rate of NHK, as expected (Fig. 2 G). Thus, the fates of ERAD-L 
substrates in cells defective in mannose trimming differ depend-
ing on the substrate examined.
We hypothesized that chicken and human cells are able to 
extract severely misfolded glycoproteins, such as NHK contain-
ing C-terminal large truncation, from gpERAD and target them 
to non-gpERAD, which degrades substrates such as NHK-QQQ 
(Fig. 2 B). To probe this hypothesis, we introduced various dele-
tions into hATF6α(C)-TAP to exacerbate its degree of misfold-
ing. At the same time, we removed the 2×IgG binding domain 
from hATF6α(C)-TAP to make hATF6α(C)-myct, on the basis 
that the presence of such a folded domain may obscure the ef-
fect of deletion on the folding status of hATF6α(C) (Fig. 3 A). 
This hATF6α(C)-myct was markedly stabilized in gEDEM-
TKO cells (Fig. 3 C). We then constructed its three deletion 
mutants (Fig. 3 A). All four proteins entered the ER and be-
came glycosylated, as they migrated slightly more slowly 
in gEDEM-TKO cells than in WT cells during SDS-PAGE, 
and the difference in migration was lost after EndoH treat-
ment (Fig. 3 B). Cycloheximide chase experiments revealed 
that the deletion of aa 280–298 did not significantly affect 
the stability of hATF6α(C)-myct (Fig. 3 D). In contrast, the 
Δ111–119, 182–194 mutant and Δ219–270 mutant became 
very unstable in gEDEM-TKO cells and behaved very simi-
larly to NHK; their degradation was delayed only at the early 
chase periods in gEDEM-TKO cells, and they were eventu-
ally degraded in both WT and gEDEM-TKO cells (Fig. 3, E 
and F). It should be noted that degradation of all four glyco-
proteins was blocked by MG132 treatment in both WT and 
gEDEM-TKO cells (Fig. S2 C).
To determine whether the folding status of the four 
glycoproteins is correlated with their fates in gEDEM-TKO 
cells, we used several approaches. It was previously shown 
that a denatured glycoprotein is more susceptible to mannose 
trimming by ERmanI than a native protein (Aikawa et al., 
2012). In this connection, we noticed that when cells were lysed 
directly in SDS sample buffer, hATF6α(C)-myct1-302 and the 
Δ280–298 mutant were detected as a single band, whereas the 
Δ111–119, 182–194 and Δ219–270 mutants were detected as 
a doublet, although slower bands were predominant (Fig. S3 
A). When cells were lysed with digitonin and then mixed with 
2× SDS sample buffer, faster bands of hATF6α(C)-myct1-302 
and the Δ280–298 mutant appeared, and levels of faster bands 
of the Δ111–119, 182–194 and Δ219–270 mutants increased 
(Fig. S3 A). We interpret this appearance of faster bands upon 
lysis with digitonin to represent partial deglycosylation of 
hATF6α(C) derivatives by peptide :N -glycanase (PNGase), 
an enzyme responsible for deglycosylation of glycoproteins 
dislocated from the ER to the cytosol (Misaghi et al., 2004), 
for three reasons. First, both bands were sensitive to EndoH 
treatment (Fig. S3 B); second, the appearance of the faster 
band of the Δ111–119, 182–194 mutant was significantly 
inhibited by Z-VAD-fmk (Fig. S3 C), which inhibits PNGase; 
and third, the faster band of the Δ111–119, 182–194 mutant 
did not appear in mouse embryonic fibroblast (MEF) cells 
deficient in PNGase but did appear in MEF cells deficient in 
the cytosolic endo-β-N-acetylglucosaminidase (ENGase; Fig. 
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Figure 1. Effect of EDEM-TKO on N-glycan profiles and ATF6α degradation. (A) RT-PCR to amplify cDNA corresponding to gEDEM1/2/3 mRNA in DT40 
cells of various genotypes and doubling times of WT and gEDEM-TKO cells. (B) Isomer composition of N-glycans prepared from total cellular glycoproteins 
of WT, WT treated with kifunensine (Kif, 10 µg/ml, 6 h), and gEDEM-TKO cells. This experiment was completed once. (C) RT-PCR to amplify cDNA corre-
sponding to hEDEM1/2/3 mRNA in WT and hEDEM-TKO cells and their doubling times. The asterisk denotes a nonspecific band. (D) Isomer composition 
of N-glycans prepared from total cellular glycoproteins of WT, WT treated with kifunensine (10 µg/ml, 12 h), and hEDEM-TKO cells. This experiment was 
completed once. (E) Cycloheximide chase to determine the degradation rate of endogenous gATF6 (only one ATF6 gene in chicken genome) in WT and 
gEDEM-TKO cells using anti-gATF6 (n = 3). (F) Pulse-chase to determine the degradation rate of endogenous hATF6α in WT and hEDEM-TKO cells using an-
ti-hATF6α (n = 3). (G) Cycloheximide chase to determine the degradation rate of transfected hATF6α(C)-TAP in WT and gEDEM-TKO cells using anti–c-myc 
(n = 3). (E–G) Means ± SD are shown. *, P < 0.05; **, P < 0.01. (H) Immunoblotting of cell lysates prepared from WT and gEDEM-TKO cells expressing 
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of faster bands in PNGase sensitivity assay in cell lysates 
indicated that the Δ111–119, 182–194 and Δ219–270 mutants 
were more misfolded than hATF6α(C)-myct1-302 and the 
Δ280–298 mutant (Fig. S3 E).
It was also previously reported that a misfolded protein is 
more susceptible to trypsin digestion than a folded protein (Izawa 
et al., 2012; Xu et al., 2013). The results of trypsin sensitivity 
assay suggested that the Δ111–119, 182–194 and Δ219–270 
Figure 2. Effect of EDEM-TKO on NHK degradation. (A) Immunoblotting of cell lysates prepared from WT and gEDEM-TKO cells expressing transfected 
NHK with or without EndoH treatment and those expressing transfected NHK-QQQ, using anti-α1PI. NHK* denotes the nonglycosylated NHK. (B) Pulse-
chase to determine the degradation rate of transfected NHK-QQQ in WT and gEDEM-TKO cells using anti-α1PI (n = 3). (C) Pulse-chase to determine the 
degradation rate of transfected NHK in WT and gEDEM1/2/3 single KO cells using anti-α1PI (n = 3). (D) Pulse-chase to determine the degradation rate 
of transfected NHK in WT and gEDEM-TKO cells using anti-α1PI (n = 3). (E) Pulse-chase to determine the degradation rate of transfected NHK in WT 
DT40 cells and those treated with kifunensine (10 µg/ml) or MG132 (30 µM) using anti-α1PI (n = 3). (F) Pulse-chase to determine the degradation rate of 
transfected NHK in WT and hEDEM1/2/3 single KO cells using anti-α1PI (n = 3). (G) Pulse-chase to determine the degradation rate of transfected NHK 
in WT and hEDEM-TKO cells in the presence or absence of kifunensine (10 µg/ml) using anti-α1PI (n = 3). (H) Pulse-chase to determine the degradation 
rate of transfected NHK in WT HCT116 cells and those treated with kifunensine (10 µg/ml) or MG132 (20 µM) using anti-α1PI (n = 3). (B–H) Means ± SD 
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mutants were more misfolded than hATF6α(C)-myct1-302 and 
Δ280–298 mutant (Fig. S3 F).
To substantiate our hypothesis further, we determined 
whether severely misfolded glycoproteins are degraded by 
non-gpERAD in human cells also. For this, we focused on 
mouse CD3-δ-ΔTM, an ERAD-Ls substrate containing three 
potential N-glycosylation sites (Fig.  4  A; Bernasconi et al., 
2010), which is localized in the ER (Fig. 4 B), because a part of 
hATF6α(C)-myct1-302 was secreted into medium in HCT116 
cells (not depicted), contrary to its full retention in the ER of 
DT40 cells. The results of the PNGase sensitivity assay in cell 
lysates suggested that the two insertion mutants were more 
misfolded than WT (Fig. 4 C). We found that degradation of ex-
ogenously expressed mCD3-δ-ΔTM was delayed in hEDEM-
TKO cells (Fig.  4  D) to a similar extent to that in WT cells 
treated with MG132 (Fig. 4 E) or kifunensine (not depicted). 
Importantly, insertion of 7 aa (Pro-Ala-Pro-Ala-Pro-Ala-Pro) 
between 33 and 34 aa (mCD3-δ-ΔTM<33-7aa-34>) or 70 and 
71 aa (mCD3-δ-ΔTM<70-7aa-71>), present in the second or 
sixth β-sheet, respectively, in the case of human CD3-δ (Fig. 
S3 G) resulted in similar degradation of the mutant proteins 
in the two types of cells, except for a delay at the early chase 
period in hEDEM-TKO cells (Fig. 4 F), despite their localiza-
tion in the ER (Fig. 4 B).
We further found that the type I transmembrane human 
protein EMC1 containing three potential N-glycosylation sites 
(Fig. 5 A), a subunit of the ER membrane protein complex con-
sisting of six subunits (EMC1–EMC6; Jonikas et al., 2009), be-
haved like ATF6α. Endogenous hEMC1 turned over slowly in WT 
HCT116 cells, and its turnover was delayed in hEDEM-TKO cells 
(Fig. 5 B). Exogenously expressed Flag-tagged hEMC1 was local-
ized in the ER (Fig. 5 C) and behaved very similarly to endogenous 
hEMC1 (Fig. 5 E). Importantly, however, its Δ35–220 mutant, 
which lacks most of the pyrroloquinoline quinone (PQQ) domain 
Figure 3. Effect of EDEM-TKO on hAT-
F6α(C)-myct degradation. (A) Schematic struc-
tures of hATF6α, hATF6α(C)-TAP, hATF6α(C)-myct, 
and its three deletion mutants. bZIP and TMD 
denote basic leucine zipper and transmem-
brane domains, respectively. N indicates a po-
tential glycosylation site. Both the amino acids 
111–119 and 182–194 are expected to form 
an α-helix. (B) Immunoblotting of cell lysates 
prepared from WT and gEDEM-TKO cells ex-
pressing one of the four hATF6α(C) derivatives 
by transfection with or without EndoH treat-
ment using anti–c-myc. (C–F) Cycloheximide 
chase of WT and gEDEM-TKO cells expressing 
one of the four hATF6α(C) derivatives by trans-
fection using anti–c-myc (n = 3). Means ± SD 
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containing the β-propeller repeat (Kopec and Lupas, 2013), was 
localized in the ER (Fig. 5 C), was more sensitive to trypsin and 
therefore more misfolded than hEMC1-Flag (Fig. 5 D), and was 
degraded similarly in the two types of cells, except for a delay at 
the early chase period in hEDEM-TKO cells (Fig. 5 E).
Our results identified a previously unnoticed system oper-
ating in the ER. Chicken and human cells can degrade severely 
misfolded glycoproteins in the absence of EDEM-mediated 
mannose trimming. This novel quality control cannot be easily 
discerned by knocking down EDEM1/2/3 singularly, and was 
accordingly identified for the first time here after our construc-
tion of EDEM-TKO cells in combination with our comparison 
of the fates of ATF6α and NHK. Based on the results reported 
for recombinant human ERmanI (Aikawa et al., 2012), we con-
sider that ERmanI cannot trim Man9GlcNAc2 present in na-
tive but unstable or somewhat unfolded glycoproteins, leading 
Figure 4. Effect of EDEM-TKO on mCD3-δ–ΔTM degradation. (A) Schematic structures of WT and two insertion mutants of mCD3-δ–ΔTM. (B) Immunoflu-
orescence of HCT116 cells expressing transfected WT or insertion mutant of mCD3-δ–ΔTM using anti-HA. (C) PNGase sensitivity assay of WT and two 
insertion mutants of mCD3-δ–ΔTM expressed in HCT116 cells by transfection (immunoblotting with anti-HA). The asterisk denotes partially deglycosylated 
mCD3-δ–ΔTM. (D) Pulse-chase to determine the degradation rate of transfected WT mCD3-δ–ΔTM in WT and hEDEM-TKO cells using anti-HA (n = 3). 
(E) Pulse-chase to determine the degradation rate of transfected WT mCD3-δ–ΔTM in WT cells and those treated with 40 µM MG132 using anti-HA. This 
experiment was completed once. (F) Pulse-chase to determine the degradation rate of transfected insertion mutants of mCD3-δ–ΔTM in WT and hEDEM-TKO 
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Figure 5. Effect of EDEM-TKO on hEMC1 degradation. (A) Schematic structures of WT and deletion mutant of hEMC1. (B) Pulse-chase to determine the 
degradation rate of endogenous hEMC1 in WT and hEDEM-TKO cells using anti-hEMC1. This experiment was completed once. (C) Immunofluorescence of 
HCT116 cells expressing transfected hEMC1-Flag or hEMC1-ΔPQQ-Flag using anti-Flag. (D) Trypsin sensitivity assay of hEMC1-Flag and hEMC1-ΔPQQ-
Flag expressed in HCT116 cells by transfection (immunoblotting with anti-Flag). The data shown are from a single representative experiment out of two 
repeats. (E) Pulse-chase to determine the degradation rate of transfected hEMC1-Flag and hEMC1-ΔPQQ-Flag, as well as endogenous hEMC1 in WT and 
hEDEM-TKO cells using anti-hEMC1 (n = 3). Means ± SD are shown. *, P < 0.05; **, P < 0.01. (F) Model. Newly synthesized polypeptides of non-glyco-
proteins are subjected to productive folding. Folded non-glycoproteins are secreted, whereas unfolded or misfolded proteins are targeted to non-gpERAD 
for proteasomal degradation. Newly synthesized polypeptides of glycoproteins are subjected to N-glycosylation and productive folding. Folded glyco-
proteins are secreted, whereas native but unstable glycoproteins, somewhat unfolded glycoproteins, and severely misfolded glycoproteins are subjected 
to EDEM-mediated mannose trimming, followed by proteasomal degradation via gpERAD. In addition, severely misfolded glycoproteins are subjected to 











Published November 16, 2015
JCB • Volume 211 • NumBer 4 • 2015782
to marked stabilization of ATF6α in EDEM2 single KO cells 
(Ninagawa et al., 2014), but can trim Man9GlcNAc2 present 
in severely misfolded glycoproteins, such as NHK, to produce 
Man8GlcNAc2 in EDEM2 single KO cells, which is trimmed 
to Man7GlcNAc2 by EDEM3/1 for proteasomal degradation 
(Fig. 2 F). Indeed, degradation of NHK was markedly blocked 
by kifunensine, which inhibits both ERmanI and EDEM1/2/3, 
at the early chase period (1.5 h) in HCT116 cells (Fig. 2, G and 
H). This also explains the apparent blockade of NHK degrada-
tion by kifunensine observed at the early chase periods (1–2 h) 
in previous studies (Hosokawa et al., 2001; Hirao et al., 2006). 
Complete blockade at 3-h chase (Liu et al., 1999) was not re-
produced in either recent studies (Pan et al., 2011; Fujimori et 
al., 2013) or here (Fig. 2, G and H).
This protein structure–based decision is made only in 
higher eukaryotes because yeast does not possess an efficient 
non-gpERAD (Jakob et al., 2001; Kostova and Wolf, 2005). In 
marked contrast, degradation of NHK-QQQ is much more effi-
cient than that of NHK in both mammalian (Hosokawa et al., 
2008) and DT40 cells (compare Fig. 2 B with Fig. 2 D). This 
explains why the delay in NHK degradation at the early chase 
periods in EDEM-TKO cells was canceled in the later chase pe-
riods (Fig. 2, D and G).
The next obvious question is what molecules extract se-
verely misfolded glycoproteins from gpERAD and target them 
to non-gpERAD (protein X in Fig. 5 F). Identification of the 
switch will further enhance our understanding of the protein 
quality control operating in the ER.
Materials and methods
Construction of plasmids
Recombinant DNA techniques were performed according to standard 
procedures (Sambrook et al., 1989). The integrity of all constructed 
plasmids was confirmed by extensive sequencing analyses. Site-di-
rected mutagenesis was performed using Dpn I. p3*flag-CMV-14 Ex-
pression Vector (Sigma-Aldrich) was used to express a protein tagged 
with Flag at the C terminus. Platinum transcription activator-like ef-
fector nuclease plasmids to knock out hEDEM family genes were con-
structed previously (Ninagawa et al., 2014).
Reagents
Puromycin (0.5 µg/ml), histidinol (1 mg/ml), mycophenolic acid (15 
µg/ml), blasticidin S (25 µg/ml), G418 (2 mg/ml for DT40 and 0.6 mg/ml 
for HCT116), and Zeocin (1 mg/ml) were used for the selection and 
maintenance of drug-resistant clones. Kifunensine was purchased from 
Cayman Chemical Company, EndoH from EMD Millipore, cyclohexi-
mide from Sigma-Aldrich, MG132 from Peptide Institute, Z-VAD-fmk 
from Promega, trypsin from Nacalai Tesque, and digitonin from Wako 
Pure Chemical Industries.
Cell culture, transfection, and N-glycan profiling
DT40 cells were cultured and transfected as described previously 
(Ninagawa et al., 2011). HCT116 cells (ATCC CCL-247) and MEF 
cells were cultured in Dulbecco’s modified Eagle’s medium (glucose 
4.5 g/liter) supplemented with 10% fetal bovine serum, 2 mM gluta-
mine, and antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin) 
at 37°C in a humidified 5% CO2/95% air atmosphere and transfected 
using Lipofectamine 2000 (Invitrogen) or X-tremeGENE 9 (Roche) 
according to the manufacturers’ instructions. Doubling times were 
determined by counting cell numbers every 24 h for a total of 120 h 
for DT40 cells, and every 48 h for a total of 192 h for HCT116 cells. 
Each value represents the mean of triplicate determinations. Pyridyl-
amination and structural identification of N-glycans of total cellular 
glycoproteins were performed as described previously (Horimoto et al., 
2013; Ninagawa et al., 2014).
Immunological techniques
Immunoblotting analysis was performed according to the stan-
dard procedure (Sambrook et al., 1989) as described previously 
(Ninagawa et al., 2011). Chemiluminescence obtained using West-
ern Blotting Luminol Reagent (Santa Cruz Biotechnology, Inc.) was 
detected using an LAS-3000mini Lumino Image analyzer (Fujifilm). 
Rabbit anti–chicken ATF6 (Horimoto et al., 2013) and anti–human 
ATF6α (Haze et al., 1999) antibodies were raised previously. Rab-
bit polyclonal anti-EMC1 antibody, which reacts with both chicken 
and human EMC1, was raised against human EMC1 (529–943 aa) 
fused to glutathione S-transferase. Anti–c-myc antibody (9E10) was 
obtained from Wako Pure Chemical Industries, anti-Flag antibody 
from Sigma-Aldrich, anti-HA antibody from Recenttec, anti-KDEL 
antibody from Medical and Biological Laboratories, anti-ATF4 and 
anti-XBP1 antibodies from Santa Cruz Biotechnology, Inc., and an-
ti-α1PI antibody from Dako.
Pulse-chase experiments using 9.8 MBq/dish EASY TAG EXP 
RESS Protein labeling mix [35S] (PerkinElmer) and subsequent im-
munoprecipitation using anti–human ATF6α, anti-α1PI, anti–human 
EMC1, anti-Flag, or anti-HA antibody and protein A–coupled Sepharose 
beads (GE Healthcare) were performed according to procedures de-
scribed previously (Ninagawa et al., 2011).
For immunofluorescence analysis, HCT116 cells transfected 
using X-tremeGENE 9 were fixed by incubation on ice for 6.5 min 
in methanol/acetone (1:1). Anti-Sec61β antibody was obtained from 
Proteintech. Secondary antibodies labeled with FITC and CF594 were 
obtained from ICN Biomedicals and Biotium, respectively. Microscope 
images were obtained at room temperature with 40 magnification using 
a DM IRE2 and confocal software (both from Leica).
PNGase sensitivity assay
HCT116 cells at 24 h after transfection or DT40 cells at 16 h after 
transfection were washed with PBS, collected, and suspended in 200 µl 
buffer A (50 mM Tris/HCl, pH 8.0, containing 1% NP-40 [for mamma-
lian cells] or 1% digitonin [for chicken cells], 150 mM NaCl, protease 
inhibitor cocktail [Nacalai Tesque], and 20 µM MG132). Lysates were 
left on ice for 20 min and clarified by centrifugation at 14,000 rpm 
for 10 min at 4°C. After incubation for various periods on ice, cleared 
lysates were mixed with 2× SDS sample buffer containing 100 mM 
dithiothreitol and 2 µM Z-VAD-fmk, boiled for 5 min, and subjected to 
SDS-PAGE followed by immunoblotting.
Trypsin sensitivity assay
DT40 cells or HCT116 cells transfected were washed with PBS 
three times, collected, and suspended in 250  µl (for DT40 cells) 
or 400 µl (for HCT116 cells) buffer B (50 mM Tris/HCl, pH 8.0, 
containing 1% NP-40, 150 mM NaCl, 2 µM Z-VAD-fmk, and 20 µM 
MG132). Lysates were left on ice for 20 min and clarified by cen-
trifugation at 14,000 rpm for 10 min at 4°C. Cleared lysates were 
incubated with various concentrations of trypsin for 15 min at 4°C 
and then mixed with 2× SDS sample buffer containing 100  mM 
dithiothreitol and 10× protease inhibitor cocktail (Nacalai Tesque), 
boiled for 5 min, and subjected to SDS-PAGE followed by immu-
noblotting. The presence of equal amounts of proteins in cleared 
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Southern blot hybridization
Southern blot hybridization was performed according to standard pro-
cedures (Sambrook et al., 1989) as described previously (Ninagawa 
et al., 2011). Specific probes were prepared as described previously 
(Ninagawa et al., 2014) and labeled with digoxigenin. Subsequent 
reaction with anti-digoxigenin antibody (Roche) and treatment with 
the chemiluminescent detection reagent CDP-star (GE Healthcare) 
were performed according to the manufacturers’ specifications. Che-
miluminescence was visualized using an LAS-3000mini Lumino 
Image analyzer (Fujifilm).
Genomic PCR
Homologous recombination in HCT116 cells was confirmed by genomic 
PCR using a pair of primers described previously (Ninagawa et al., 2014).
RT-PCR
Total RNA prepared from WT DT40 cells or various KOs (∼5 × 106 
cells) and from WT HCT116 cells or various KOs (∼3 × 106 cells) 
by the acid guanidinium/phenol/chloroform method using ISO GEN 
(Nippon Gene) was converted to cDNA using Moloney murine leu-
kemia virus reverse transcription (Invitrogen) and random primers. 
The full-length open reading frame of gEDEM1, gEDEM2, gEDEM3, 
hEDEM1, hEDEM2, or hEDEM3 was amplified using PrimeSTAR HS 
DNA polymerase (Takara Bio Inc.) and a pair of primers described 
previously (Ninagawa et al., 2014).
Construction of gEDEM-TKO DT40 cells
We previously constructed gEDEM1, gEDEM2, or gEDEM3 single 
KO DT40 cells (Ninagawa et al., 2014). We then constructed double 
KO cells deficient in gEDEM1 and gEDEM2, gEDEM2 and gEDEM3, 
and gEDEM1 and gEDEM3 (Fig. S1 A). Homologous recombination 
was checked by Southern blotting (Fig. S1 B), and RT-PCR analysis re-
vealed the expected expression of each mRNA (Fig. S1 C). We further 
constructed TKO cells deficient in gEDEM1, gEDEM2, and gEDEM3 
(Fig. S1 A, right). Homologous recombination was checked by South-
ern blotting (Fig. S1 B), and RT-PCR analysis revealed the expected 
expression of each mRNA (Fig. S1 C).
Construction of hEDEM-TKO HCT116 cells
We previously constructed hEDEM1, hEDEM2, or hEDEM3 single 
KO HCT116 cells (Ninagawa et al., 2014). We disrupted the hEDEM2 
gene in hEDEM3 single KO cells and then disrupted the hEDEM1 gene 
in the resulting hEDEM2/3 double KO cells to create hEDEM-TKO 
HCT116 cells (Fig. S2 A).
Online supplemental material
Fig. S1 shows the generation of DT40 cells deficient in two or three 
of gEDEM1/2/3.  Fig. S2 shows the generation and characterization 
of hEDEM-TKO cells and the effect of MG132 on the stability of 
hATF6α(C) derivatives in DT40 cells. Fig. S3 shows analysis of folding 
status of hATF6α(C) derivatives in DT40 cells. Online supplemental 
material is available at http ://www .jcb .org /cgi /content /full /jcb 
.201504109 /DC1. Additional data are available in the JCB DataViewer 
at http ://dx .doi .org /10 .1083 /jcb .201504109 .dv.
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